ERBB3 and breast carcinoma: ERBB3 coamplification/comutation was seen in ERBB2mut and ERBB2amp bladder cancer (9.9% and 7.8%, respectively), in ERBB2mut breast cancer (9.7%), and in ERBB2mut CRC (6.6%) but was more rare in other tumors.